Auour Investments LLC bought a new position in shares of Atea Pharmaceuticals, Inc. (NASDAQ:AVIR – Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 177,000 shares of the company’s stock, valued at approximately $662,000. Auour Investments LLC owned about 0.21% of […]